Why the study?
When should dual antiplatelet therapy be interrupted for surgery in patients who have undergone percutaneous coronary intervention?
When should dual antiplatelet therapy be interrupted for surgery in patients who have undergone percutaneous coronary intervention?
This review provides guidance on the perioperative management of dual antiplatelet therapy based on the 2016 ACC/AHA guidelines for patients with prior PCI.
Answers are grounded in this paper and cite their sources.
Supports guideline-directed DAPT durations for perioperative planning; leaves open need for updated trial evidence beyond 2016 recommendations.
receptor inhibitor, clopidogrel, prasugrel, or ticagrelor. Such therapy is a cornerstone of medical management following acute coronary syndromes and is imperative following percutaneous coronary interventions. While there is uncertainty about the optimal duration of dual antiplatelet therapy following percutaneous coronary intervention, the new 2016 American College of Cardiology/American Heart Association Guidelines suggest that for patients with stable ischemic heart disease at least six months of such therapy following a drug eluting stent and one month following a bare metal stent should be implemented. In patients with acute coronary syndrome including non-ST elevation and ST elevation myocardial infarction it is recommended to extend dual antiplatelet therapy treatment to one year in both drug eluting stent and bare metal stent groups. There may be latitude for earlier discontinuation in appropriately selected patients; extended dual antiplatelet therapy beyond one year may be beneficial in others. Herein, we describe current guidelines and evidence supporting if and when dual antiplatelet therapy should be interrupted for surgery for patients who have undergone percutaneous coronary intervention.
No takes yet. Share an insight, caveat, or question.
Webster et al. (2016) conducted a review in Acute coronary syndromes and percutaneous coronary interventions. Dual antiplatelet therapy was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: